LIVING GUIDELINES FOR DIABETES (LG4D)
Diabetes is an National Health Priority area that affects approx. 1.7 million Australians and represents an estimated $15 billion per annum in direct and indirect costs to the Australian economy.
As part of the implementation plan for the Australian National Diabetes Strategy 2016-2020, several key diabetes organisations are partnering to establish two living evidence demonstration projects in areas that reflect a high priority for decision making in diabetes management, and where there is uncertainty in the existing evidence and a high likelihood of emerging evidence:
Recommendations for which therapies are best for blood glucose control in type 2 diabetes?
Recommendations for the use of technology for managing diabetes (eg pumps, continuous glucose monitoring, flash glucose monitoring).
The LG4D project is a partnership between Australian Diabetes Society, Diabetes Australia, Australian Diabetes Educators Society, Australian Paediatric Endocrine Group and Cochrane Australia and is supported by the Australian government Department of Health.
For more information about this frontier project please contact Professor Sophia Zoungas, firstname.lastname@example.org